Home - Products - Angiogenesis - PDE - SEP-0372814

SEP-0372814

CAS No. 1516895-53-6

SEP-0372814( —— )

Catalog No. M21943 CAS No. 1516895-53-6

SEP-0372814 is a potent inhibitor of PDE10.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	178	In Stock
5MG	268	In Stock
10MG	408	In Stock
25MG	672	In Stock
50MG	945	In Stock
100MG	1278	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

SEP-0372814
Note

Research use only, not for human use.
Brief Description

SEP-0372814 is a potent inhibitor of PDE10.
Description

SEP-0372814 is a potent inhibitor of PDE10.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

PDE
Recptor

PDE10
Research Area

——
Indication

——

Chemical Information

CAS Number

1516895-53-6
Formula Weight

369.42
Molecular Formula

C21H19N7
Purity

>98% (HPLC)
Solubility

——
SMILES

Cc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

MK-0873

MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
Doxofylline

Doxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.
Verofylline

Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.

Sign In Join Free